Onderzoeker
Brecht Creyns
- Disciplines:Immunologie, Laboratoriumgeneeskunde
Affiliaties
- Onderzoeksgroep Allergie en Klinische Immunologie (Afdeling)
Lid
Vanaf15 sep 2015 → 30 jun 2021
Projecten
1 - 1 of 1
- De rol van aangeboren lymfoïde cellen in chronische colitis en intestinale fibroseVanaf15 sep 2015 → 24 jan 2020Financiering: FWO Strategische Onderzoeksbeurs
Publicaties
11 - 16 van 16
- Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease(2018)
Auteurs: Bram Verstockt, Gert De Hertogh, Brecht Creyns, Gert Van Assche, Marc Ferrante, Jan Ceuppens, Séverine Vermeire, Christine Breynaert
Pagina's: 1 - 9 - PREDICTIVE SEROLOGICAL MARKERS OF RESPONSE TO USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN'S PROVIDE NOVEL INSIGHTS IN THE MECHANISM OF ACTION(2018)
Auteurs: Bram Verstockt, Séverine Vermeire, Sare Verstockt, Brecht Creyns, Nooshin Ardeshir Davani, Christine Breynaert, Gert Van Assche, Marc Ferrante
Pagina's: S187 - S187 - Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications(2018)
Auteurs: Inge Kortekaas Krohn, Christine Breynaert, Brecht Creyns, Peter Hellings, Sven Seys
Pagina's: 837 - 850 - Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease(2018)
Auteurs: Brecht Creyns, Bram Verstockt, J Cremer, Marc Ferrante, Séverine Vermeire, C Jan, Gert Van Assche, Christine Breynaert
Pagina's: S41 - S42 - Serum markers predict outcome to ustekinumab in patients with refractory Crohn's disease and provide insides in the mechanism of action(2018)
Auteurs: Bram Verstockt, Séverine Vermeire, Sare Verstockt, Brecht Creyns, N Ardeshir Davani, Christine Breynaert, Gert Van Assche, G Van Assche, Marc Ferrante
Pagina's: S110 - S110 - Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
Auteurs: Jochen Belmans, Matthias Van Woensel, Brecht Creyns, Joost Dejaegher, Dominique Bullens, Stefaan Van Gool
Pagina's: 13902